In the US healthcare system, medication mismanagement costs over $528 billion annually and contributes to roughly 275,000 deaths each year. Operating at scale across this problem, 45+ health plans using medication intelligence platforms that integrate clinical, behavioural, and social determinants of health data are moving beyond reactive approaches to identifying risks before they become hospitalisations or adverse events. A platform relying on machine learning and data science, paired with clinical expertise, can generate tens of millions of treatment recommendations yearly. Some health plans deploying such technology report hospitalisations reduced by up to 40%, total cost of care cut by 10–15%, and improved quality ratings that cross the 4–5 star threshold.
What distinguishes an effective platform is its ability to process vast amounts of integrated data - spanning pharmacy claims, clinical records, behavioural signals, and social factors - in order to flag medication-related risks before they manifest as harm. The scope of such work is substantial: systems supporting 30+ million members can produce 40+ million actionable recommendations annually, each one aimed at optimising individual medication regimens and reducing preventable complications.
Healthcare organisations pursuing medication optimisation are seeking partners with demonstrable track records of impact reduction in hospitalisation, cost containment, and quality improvement. Success depends on seamless data integration, robust machine learning models trained on clinical outcomes, and the ability to translate algorithmic insights into decisions that clinicians and health systems can act upon quickly.